{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:11:08Z","timestamp":1786997468310,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.thromres.2019.07.009","type":"journal-article","created":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T10:30:33Z","timestamp":1563013833000},"page":"135-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Increasing use of anticoagulants in Germany and its impact on hospitalization for gastrointestinal bleeding"],"prefix":"10.1016","volume":"181","author":[{"given":"Jan-Erik","family":"Guelker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Ilousis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans","family":"Santosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Kowall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Stang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2019.07.009_bb0005","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2019.07.009_bb0010","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.thromres.2019.07.009_bb0015","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2019.07.009_bb0020","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1160\/TH11-07-0517","article-title":"Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET\/EHRA consensus conference","volume":"106","author":"Kirchhof","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2019.07.009_bb0025","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/eurheartj\/ehq117","volume":"31","author":"Lip","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.thromres.2019.07.009_bb0030","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/blood-2014-04-571232","article-title":"Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials","volume":"124","author":"van Es","year":"2014","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2019.07.009_bb0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1055\/s-0038-1637750","article-title":"Direct oral anticoagulants and the paradigm shift in the management of venous thromboembolism","volume":"44","author":"Lim","year":"2018","journal-title":"Semin Thromb Hemost."},{"key":"10.1016\/j.thromres.2019.07.009_bb0040","unstructured":"Weckbecker K, Bleckwenn M, Dinkel K, M\u00fccke M. Einsatz der Neuen oralen Antikoagulanzien in Hausarztpraxen. DOI: https:\/\/doi.org\/10.3238\/zfa.2016.0028-0032"},{"key":"10.1016\/j.thromres.2019.07.009_bb0045","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.thromres.2014.10.002","article-title":"A meta-analysis of phase III randomized controlled trials with novel oral anticoagulants in atrial fibrillation: Comparisons between direct thrombin inhibitors vs. factor Xa inhibitors and different dosing regimens","volume":"134","author":"Provid\u00eancia","year":"2014","journal-title":"Thrombosis Research"},{"key":"10.1016\/j.thromres.2019.07.009_bb0050","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood-2014-07-590323","article-title":"The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis","volume":"124","author":"Chai-Adisaksopha","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2019.07.009_bb0055","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.jacc.2015.09.024","article-title":"Gastrointestinal bleeding in patients with atrial fibrillation treated with rivaroxaban or warfarin: ROCKET AF Trial","volume":"66","author":"Sherwood","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2019.07.009_bb0060","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/1756283X17702092","article-title":"Direct oral anticoagulants and digestive bleeding: therapeutic management and preventive measures","volume":"10","author":"Deutsch","year":"2017","journal-title":"Therap Adv Gastroenterol."},{"key":"10.1016\/j.thromres.2019.07.009_bb0065","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1053\/j.gastro.2013.09.041","article-title":"Increase of gastrointestinal bleeding with new oral anticoagulants: problems of a meta-analysis","volume":"145","author":"Beyer-Westendorf","year":"2013","journal-title":"Gastroenterology."},{"key":"10.1016\/j.thromres.2019.07.009_bb0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10654-010-9543-4","article-title":"Nationwide rates of conversion from laparoscopic or vaginal hysterectomy to open abdominal hysterectomy in Germany","volume":"26","author":"Stang","year":"2011","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.thromres.2019.07.009_bb0075","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10654-013-9816-9","article-title":"Effect of mammography screening on surgical treatment for breast cancer: a nationwide analysis of hospitalization rates in Germany 2005\u20132009","volume":"28","author":"Stang","year":"2013","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.thromres.2019.07.009_bb0080","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1007\/s10620-017-4882-6","article-title":"Changing epidemiology of upper gastrointestinal hemorrhage in the last decade: a nationwide analysis","volume":"63","author":"Wuerth","year":"2018","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.thromres.2019.07.009_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.gie.2014.09.027","article-title":"The in-hospital mortality rate for upper GI hemorrhage has decreased over 2 decades in the United States: a nationwide analysis","volume":"81","author":"Abougergi","year":"2015","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/j.thromres.2019.07.009_bb0090","doi-asserted-by":"crossref","first-page":"10890","DOI":"10.3748\/wjg.v21.i38.10890","article-title":"Upper gastrointestinal bleeding in Scotland 2000\u20132010: improved outcomes but a significant weekend effect","volume":"21","author":"Ahmed","year":"2015","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.thromres.2019.07.009_bb0095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.gastro.2013.02.041","article-title":"New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis","volume":"145","author":"Holster","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.thromres.2019.07.009_bb0100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/bcp.12911","article-title":"The association between non-vitamin K antagonist oral anticoagulants and gastrointestinal bleeding: a meta-analysis of observational studies","volume":"82","author":"He","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.thromres.2019.07.009_bb0105","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00535-017-1320-7","article-title":"Management and outcome of gastrointestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs","volume":"52","author":"Pannach","year":"2017","journal-title":"J Gastroenterol."},{"key":"10.1016\/j.thromres.2019.07.009_bb0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1160\/TH13-02-0150","article-title":"Gastrointestinal bleeding with the new oral anticoagulants \u2013 defining the issues and the management strategies","volume":"110","author":"Desai","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2019.07.009_bb0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/den.12316","article-title":"Characteristics of patients with non-variceal upper gastrointestinal bleeding taking antithrombotic agents","volume":"27","author":"Yamaguchi","year":"2015","journal-title":"Dig Endosc."},{"key":"10.1016\/j.thromres.2019.07.009_bb0120","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S2468-1253(17)30054-7","article-title":"Restrictive versus liberal blood transfusion for gastrointestinal bleeding: a systematic review and meta-analysis of randomised controlled trials","volume":"2","author":"Odutayo","year":"2017","journal-title":"Lancet Gastroenterol Hepatol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384819302920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384819302920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:40:13Z","timestamp":1758735613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384819302920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":24,"alternative-id":["S0049384819302920"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2019.07.009","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increasing use of anticoagulants in Germany and its impact on hospitalization for gastrointestinal bleeding","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2019.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}